Bone marrow-derived mesenchymal stem cells promote colorectal cancer progression through paracrine neuregulin 1/HER3 signalling
- PMID: 22535374
- DOI: 10.1136/gutjnl-2011-301393
Bone marrow-derived mesenchymal stem cells promote colorectal cancer progression through paracrine neuregulin 1/HER3 signalling
Abstract
Objective: Bone marrow-derived mesenchymal stem cells (BM-MSC) migrate to primary tumours and drive tumour progression. This study aimed to identify the molecular mechanisms associated with these heterotypic cellular interactions and analyse their relevance in colorectal cancer (CRC).
Design: Paracrine interactions of BM-MSC with CRC cells were studied using collagen invasion assays, cell counts, flow cytometric cell-cycle analysis and tumour xenograft models. The role of neuregulin 1 (NRG1) and the human epidermal growth factor receptor (HER) family pathways were investigated using tyrosine kinase assays, mass spectrometry, pharmacological inhibition, antibody-mediated neutralisation and RNA interference. Transmembrane neuregulin 1 (tNRG1), HER2 and HER3 expression was analysed in primary CRC (n=54), adjacent normal colorectal tissues (n=4), liver metastases (n=3) and adjacent normal liver tissues (n=3) by immunohistochemistry.
Results: BM-MSC stimulate invasion, survival and tumorigenesis of CRC through the release of soluble NRG1, activating the HER2/HER3-dependent PI3K/AKT signalling cascade in CRC cells. Similarly, tumour-associated mesenchymal cells (T-MC) in CRC demonstrate high tNRG1 expression, which is significantly associated with advanced Union for International Cancer Control stage (p=0.005) and invasion depth (p=0.04) and decreased 5-year progression-free survival (p=0.01). HER2 and HER3 show membrane localisation in cancer cells of CRC tissue.
Conclusion: Paracrine NRG1/HER3 signals initiated by BM-MSC and T-MC promote CRC cell progression, and high tNRG1 expression is associated with poor prognosis in CRC.
Similar articles
-
The interplay of HER2/HER3/PI3K and EGFR/HER2/PLC-γ1 signalling in breast cancer cell migration and dissemination.J Pathol. 2012 Jun;227(2):234-44. doi: 10.1002/path.3991. Epub 2012 Mar 21. J Pathol. 2012. PMID: 22262199
-
Deficient HER3 expression in poorly-differentiated colorectal cancer cells enhances gefitinib sensitivity.Int J Oncol. 2014 Oct;45(4):1583-93. doi: 10.3892/ijo.2014.2538. Epub 2014 Jul 8. Int J Oncol. 2014. PMID: 25017791
-
Toward the prognostic significance and therapeutic potential of HER3 receptor tyrosine kinase in human colon cancer.Clin Cancer Res. 2012 Feb 15;18(4):956-68. doi: 10.1158/1078-0432.CCR-11-1186. Epub 2011 Dec 5. Clin Cancer Res. 2012. PMID: 22142822
-
The neuregulin-I/ErbB signaling system in development and disease.Adv Anat Embryol Cell Biol. 2007;190:1-65. Adv Anat Embryol Cell Biol. 2007. PMID: 17432114 Review.
-
Association between the overexpression of Her3 and clinical pathology and prognosis of colorectal cancer: A meta-analysis.Medicine (Baltimore). 2018 Sep;97(37):e12317. doi: 10.1097/MD.0000000000012317. Medicine (Baltimore). 2018. PMID: 30212974 Free PMC article. Review.
Cited by
-
Pharmacological Inhibition and Genetic Knockdown of BCL9 Modulate the Cellular Landscape of Cancer-Associated Fibroblasts in the Tumor-Immune Microenvironment of Colorectal Cancer.Front Oncol. 2021 May 5;11:603556. doi: 10.3389/fonc.2021.603556. eCollection 2021. Front Oncol. 2021. PMID: 34026600 Free PMC article.
-
Advancements in 3D In Vitro Models for Colorectal Cancer.Adv Sci (Weinh). 2024 Aug;11(32):e2405084. doi: 10.1002/advs.202405084. Epub 2024 Jul 4. Adv Sci (Weinh). 2024. PMID: 38962943 Free PMC article. Review.
-
The multifaceted role of exosomes in cancer progression: diagnostic and therapeutic implications [corrected].Cell Oncol (Dordr). 2018 Jun;41(3):223-252. doi: 10.1007/s13402-018-0378-4. Epub 2018 Apr 17. Cell Oncol (Dordr). 2018. PMID: 29667069 Review.
-
Bone marrow-derived mesenchymal stem cell-secreted IL-8 promotes the angiogenesis and growth of colorectal cancer.Oncotarget. 2015 Dec 15;6(40):42825-37. doi: 10.18632/oncotarget.5739. Oncotarget. 2015. PMID: 26517517 Free PMC article.
-
Role of mesenchymal stem cell-derived fibrinolytic factor in tissue regeneration and cancer progression.Cell Mol Life Sci. 2015 Dec;72(24):4759-70. doi: 10.1007/s00018-015-2035-7. Epub 2015 Sep 9. Cell Mol Life Sci. 2015. PMID: 26350342 Free PMC article. Review.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
Miscellaneous